IC
INSM icon

Ikarian Capital’s Insmed INSM Stock Holding History

Ikarian Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$14.4M – 199
2025
Q3 		$14.4M Buy
+100,000
New +$12.3M 1.45% 14
2024
Q3 		– Sell
-709
Closed -$4.75M – 163
2024
Q2 		$4.75M Sell
709
-70,191
-99% -$2.72M 0.83% 31
2024
Q1 		$1.92M Buy
+70,900
New +$1.98M 0.21% 89

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Ikarian Capital's INSM Position: Q2 2026 in Review

Ikarian Capital sold out of Insmed (INSM) in Q2 2026, closing a stake of 4,214 shares — an estimated $689K sold.

Ikarian Capital first reported a position in INSM in Q1 2020 and held it in 15 quarters. The position peaked at $16.5M in Q2 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Ikarian Capital reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Ikarian Capital sold 4,214 Insmed shares in Q2 2026, an estimated $689K.
  • Ikarian Capital first reported a position in Insmed in Q1 2020 and held it in 15 quarters.
  • Ikarian Capital's Insmed position peaked at $16.5M in Q2 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.